Table 1.
Antibody | Source | CDRH3: CDRL3 | Gene usage | VH:VL abundance (percentage and rank) |
---|---|---|---|---|
BM1 | bone marrow | CTRSEFVNFGWFAYW: CQQYHNFPRTF | IGHV1-IGHD2-IGHJ3: IGKV4-IGKJ1 |
2.6%, 3rd: 3.1%, 3rd |
BM3 | bone marrow | CTRSEYVNFGWFAYW: CQQYHNFPRTF | IGHV1-IGHD2-IGHJ3: IGKV4-IGKJ1 |
5.1%, 2nd: 3.1%, 3rd |
BM17 | bone marrow | CTRSEYVNFGWFAYW: CQQYHNFPRTF | IGHV1-IGHD2-IGHJ3: IGKV4-IGKJ1 |
1.2%, 5th: 3.1%, 3rd |
SP1 | spleen | CSRDRTWYGTFYAMDYW: CHQYHRSPYTF |
IGHV1-IGHD2-IGHJ4: IGKV4-IGKJ2 |
0.9%,5th: 2.8%,3rd |
SP19 | spleen | CTRSEFVNFGWFAYW: CHQYHNYPRTF | IGHV1-IGHD2-IGHJ3: IGKV4-IGKJ1 |
5.3%,2nd: 1.2%,4th |